Cellergy Therapeutics News
1 article
growth-positive
MITOCHONDRIA: THE NEW FRONTIER IN HEALING A MEDICAL BREAKTHROUGH
Cellergy Therapeutics is pioneering a breakthrough therapy that infuses the bloodstream with young and healthy mitochondria to restore cellular energy and promote healing. Founded in 2022, the company aims to address congenital mitochondrial disorders in children, with broader applications planned for the future. Cellergy has overcome production scale challenges by developing a proprietary method to grow and harvest high-functioning mitochondria. Recently, the company secured $1.5 million from the Israel Innovation Authority and is raising a seed round. Clinical trials are expected to begin within a year at the Schneider Childrens Medical Center. The therapy holds promise for treating degenerative diseases and extending longevity, attracting significant interest in the field of regenerative medicine.
Product StageInvestment